Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open
Glavni autori: Hagiwara, Akiyoshi, Tanaka, Noriko, Uemura, Tatsuki, Matsuda, Wataru, Kimura, Akio
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Intensive Care
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223629/
https://ncbi.nlm.nih.gov/pubmed/28039291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012850
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items